Evidence map›Paper›PMID 34926870›Full record

ArticleKidney international reports2022

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Lauren Floyd, Mohamed E Elsayed, Tobias Seibt, Anke von Bergwelt-Baildon, Philip Seo, Brendan Antiochos, Sam Kant, Adam Morris, Ajay Dhaygude, Ulf Schönermarck and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lauren FloydDepartment of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Mohamed E ElsayedDepartment of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Tobias SeibtNephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.
Anke von Bergwelt-BaildonNephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.
Philip SeoDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
Brendan AntiochosDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
Sam KantDivision of nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
Adam MorrisDepartment of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Ajay DhaygudeDepartment of Nephrology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Ulf SchönermarckNephrology Division, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.
Duvuru GeethaDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34926870
PMCPMC8664608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.